Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4)?

Organic & Biomolecular Chemistry Pub Date: 2012-03-19 DOI: 10.1039/C2OB25107H

Abstract

The development of novel peptide and peptidomimetic ligands for the CXC chemokine receptor 4 (CXCR4) as therapeutic agents for HIV-1 infection, cancer, and immune system diseases has grown over the last decade. In this perspective article, the design of CXCR4 agonists and antagonists from endogenous stromal cell-derived factor-1 (SDF-1)/CXCL12 and horseshoe crab-derived antimicrobial peptides and their therapeutic and diagnostic applications are described.

Graphical abstract: Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4)
Recommended Literature